TherapeuticsMD, Inc. (TXMD): Revenue
$3.02M
Year ended 2025-12-31
$3.27M
Trailing 12 months to 2026-06-30
-64.9%
3-year compound annual growth
-45.8%
5-year compound annual growth
-17.3%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.02M | +71.6% | 2026-04-01, From 2025-01-01 |
| 2024-12-31 | $1.76M | +35.3% | 2026-04-01, From 2024-01-01 |
| 2023-12-31 | $1.30M | -98.1% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $69.96M | n/m | 2023-04-07, From 2022-01-01 |
| 2021-12-31 | $2.57M | -96.0% | 2023-04-07, From 2021-01-01 |
| 2020-12-31 | $64.87M | +30.7% | 2022-03-23, From 2020-01-01 |
| 2019-12-31 | $49.65M | +208.4% | 2022-03-23, From 2019-01-01 |
| 2018-12-31 | $16.10M | -4.0% | 2021-03-04, From 2018-01-01 |
| 2017-12-31 | $16.78M | -13.3% | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | $19.36M | -3.9% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $20.14M | +34.1% | 2018-02-23, From 2015-01-01 |
| 2014-12-31 | $15.03M | +71.2% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $8.78M | +129.8% | 2016-02-26, From 2013-01-01 |
| 2012-12-31 | $3.82M | +82.8% | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | $2.09M | n/a | 2014-03-05, From 2011-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $3.02M | +71.6% |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $2.98M | +19.0% |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $2.85M | +20.4% |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | $2.80M | -92.8% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $3.50M | +436.5% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $3.55M | -46.2% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $2.49M | -37.1% |
| CervoMed Inc. (CRVO) | 2025-12-31 | $4.01M | -58.9% |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $4.14M | -8.5% |
Compare TXMD, XBIO, UPB, RNAC side by side · Screen every company in Pharmaceutical Preparations ↗